Next Article in Journal
Ear Acupuncture according to the NADA (National Acupuncture Detoxification Association)
Next Article in Special Issue
Semi-Synthesis and Evaluation of Sargahydroquinoic Acid Derivatives as Potential Antimalarial Agents
Previous Article in Journal / Special Issue
Nanoemulsions of Essential Oils: New Tool for Control of Vector-Borne Diseases and In Vitro Effects on Some Parasitic Agents
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicines
Volume 6
Issue 2
10.3390/medicines6020043
medicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antioxidant, Cytotoxic, and Antimicrobial Activities of Glycyrrhiza glabra L., Paeonia lactiflora Pall., and Eriobotrya japonica (Thunb.) Lindl. Extracts

by
Jun-Xian Zhou
,
Markus Santhosh Braun
,
Pille Wetterauer
,
Bernhard Wetterauer
and
Michael Wink
*
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany
*
Author to whom correspondence should be addressed.
Medicines 2019, 6(2), 43; https://doi.org/10.3390/medicines6020043
Submission received: 27 February 2019 / Revised: 18 March 2019 / Accepted: 27 March 2019 / Published: 30 March 2019
(This article belongs to the Special Issue Biological Potential and Medical Use of Secondary Metabolites)
Browse Figures
Review Reports Versions Notes

Abstract

:
Background: The phytochemical composition, antioxidant, cytotoxic, and antimicrobial activities of a methanol extract from Glycyrrhiza glabra L. (Ge), a 50% ethanol (in water) extract from Paeonia lactiflora Pall. (Pe), and a 96% ethanol extract from Eriobotrya japonica (Thunb.) Lindl. (Ue) were investigated. Methods: The phytochemical profiles of the extracts were analyzed by LC-MS/MS. Antioxidant activity was evaluated by scavenging 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radicals and reducing ferric complexes, and the total phenolic content was tested with the Folin–Ciocalteu method. Cytotoxicity was determined with a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in murine macrophage RAW 264.7 cells. Antimicrobial activity of the three plant extracts was investigated against six bacterial strains with the broth microdilution method. Results: Only Pe showed high antioxidant activities compared to the positive controls ascorbic acid and (−)-epigallocatechin gallate (EGCG) in DPPH assay; and generally the antioxidant activity order was ascorbic acid or EGCG > Pe > Ue > Ge. The three plant extracts did not show strong cytotoxicity against RAW 264.7 cells after 24 h treatment with IC50 values above 60.53 ± 4.03 μg/mL. Ue was not toxic against the six tested bacterial strains, with minimal inhibitory concentration (MIC) values above 5 mg/mL. Ge showed medium antibacterial activity against Acinetobacter bohemicus, Kocuria kristinae, Micrococcus luteus, Staphylococcus auricularis, and Bacillus megaterium with MICs between 0.31 and 1.25 mg/mL. Pe inhibited the growth of Acinetobacter bohemicus, Micrococcus luteus, and Bacillus megaterium at a MIC of 0.08 mg/mL. Conclusions: The three extracts were low-cytotoxic, but Pe exhibited effective DPPH radical scavenging ability and good antibacterial activity; Ue did not show antioxidant or antibacterial activity; Ge had no antioxidant potential, but medium antibacterial ability against five bacteria strains. Pe and Ge could be further studied for their potential to be developed as antioxidant or antibacterial candidates.

1. Introduction

Traditional Chinese medicine (TCM) has a history of thousands of years in China. The first professional TCM book was Shen Nong’s Chinese Materia Medica written in the Eastern Han Dynasty (AD 25–220), but before that time, people already had records of plants used as medicines. With time and the development of their practical uses, the types of traditional medicines and books about them increased gradually. TCM and the secondary metabolites of TCM plants, such as the anti-malarial drug artemisinin, have been used to treat various diseases and become more and more popular in the world, based on modern pharmacological studies [1]. In vitro antioxidant activities of extracts of TCM plants have been widely studied and the strong antioxidant activity of many TCM plants has been found to be due to high phenolic contents (flavonoids, phenolic acids, lignans, tannins, coumarins, etc.) [2,3].
Aerobic metabolism is important for most cells to produce energy. This process generates free oxygen radicals or reactive oxygen species (ROS). Excessive generation of ROS may lead to oxidative chain reactions and thus an imbalance of oxidants and antioxidants in the body, and can cause molecular damage and several health conditions [4,5,6]. For example, ROS can oxidize the purine base guanosine, leading to 8-oxoguanosine; if not repaired, this transformation can lead to mutations and proteins with impaired functions. Antioxidants (present in cells or acquired via food or medicinal plants) can delay or inhibit the oxidative reactions or scavenge initiating radicals, thus limiting the oxidative damage [7,8]. The role of antioxidants can be determined by their interaction with oxidative free radicals [9]. A diversity of antioxidants is produced in plants, and phenolics constitute a major antioxidant group in many medicinal and food plants [10,11].
Glycyrrhiza glabra is one of the most frequently used traditional medicine in China and Europe since long ago [12,13]; Paeonia lactiflora is often used together with G. glabra to enhance the therapeutic effect, for example, in the prescription “Shaoyaogancaotang” [14,15]; one of the main secondary metabolite in Eriobotrya japonica, the triterpene ursolic acid, has a similar structure as 18β glycyrrhetinic acid, which is a major secondary metabolite in G. glabra. So, the three plant extracts were studied in order to compare their pharmacological effects. The species have been introduced before in Reference [16].
A methanol extract of Glycyrrhiza glabra (Ge), a 50% ethanol (in water) extract of Paeonia lactiflora (Pe), and a 96% ethanol extract of Eriobotrya japonica (Ue) were studied for their antioxidant activity as well as cytotoxicity and antimicrobial activity. The solvents for the extraction were optimized according to the literature [17,18,19]. Few studies on the antioxidant activity of these species had been conducted, or only one kind of antioxidant assay was applied; and it would also be interesting to study the antibacterial capacity of the species on different bacteria to broaden their future application. Our study may help to evaluate the therapeutic potential of the species.
The phytochemical composition of the extracts was studied by LC-MS/MS and largely confirmed from other laboratories (shown in Tables S1–S4 in the Supplementary Materials). We employed three different assays (DPPH, ABTS, and Ferric Reduction Antioxidant Potential (FRAP) assay) to examine the potential antioxidant activity of the three plant extracts, the Folin–Ciocalteu method to determine the total phenolic contents, and a MTT assay to determine a possible cytotoxicity against murine macrophage RAW 264.7 cells. Antimicrobial activity of the three plant extracts against gram-negative (E. coli XL1-Blue MRF′, Acinetobacter bohemicus) and gram-positive (Kocuria kristinae, Micrococcus luteus, Staphylococcus auricularis, and Bacillus megaterium) bacteria was analyzed using standard broth microdilution assays.

2. Materials and Methods

2.1. Plant Materials and Plant Extraction

The origins of the three TCM plants, and the extraction processes of Ge, Pe, and Ue have previously been described [16].

2.2. Reagents and Chemicals

Ascorbic acid and ferric chloride were purchased from AppliChem (Darmstadt, Germany), and gallic acid from Ferak Berlin (Berlin, Germany). Formic acid and Folin–Ciocalteu were obtained from Merck (Darmstadt, Germany), ampicillin from Panreac AppliChem (Darmstadt, Germany), and acetonitrile, 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,4,6-tris(2-pyridyl)-s-triazine (TPTZ), 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), Trolox, (−)-epigallocatechin gallate (EGCG), doxorubicin, ciprofloxacin, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) from Sigma-Aldrich (Darmstadt, Germany). The reference substances paeoniflorin and ursolic acid were obtained from Baoji Herbest Bio-Tech (Baoji, China).

2.3. Cell Lines and Bacterial Strains

Murine macrophage cell line RAW 264.7 was a gift from PD Dr. Katharina Kubatzky (Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany). Acinetobacter bohemicus DSM 102855, Kocuria kristinae DSM 20032 (formerly known as Micrococcus kristinae), Micrococcus luteus DSM 20030 (synonym Micrococcus lysodeikticus), Staphylococcus auricularis DSM 20609, and Bacillus megaterium DSM 32 were purchased from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). E. coli XL1-Blue MRF′ is a cloning strain from Stratagene (Heidelberg, Germany).

2.4. LC-MS/MS Analysis

For Ge, the LC-MS/MS analysis was performed on a Thermo Finnigan LCQ Advantage ion trap mass spectrometer (Thermo Finnigan, San Jose, CA, USA) with an ESI source, coupled to a Thermo Scientific Accela HPLC system (MS pump plus, autosampler, and PDA detector plus) (Thermo, San Jose, CA, USA) with an EC 150/2 Nucleodur 100-3 C18ec column (Macherey-Nagel, Düren, Germany). A gradient of water and acetonitrile (ACN) with 0.1% formic acid each for ESI+ and ESI-mode was applied from 20% to 80% ACN in 20 min at 20 °C. The flow rate was 0.3 mL/min. The injection volume was about 25 µL. The MS was operated with a capillary voltage of 10 V (ESI+) or -10 V (ESI-), source temperature of 240 °C, and high purity nitrogen as a sheath and auxiliary gas at a flow rate of 70 and 10 (arbitrary units), respectively.
For Pe and Ue, the LC-MS/MS analysis was performed on a Finnigan LCQ-Duo ion trap mass spectrometer with an ESI source (ThermoQuest, San Jose, CA, USA), coupled to a Thermo Scientific Accela HPLC system (MS pump plus, autosampler, and PDA detector plus) (Thermo, San Jose, CA, USA) with an EC 150/3 Nucleodur 100-3 C18ec column (Macherey-Nagel, Düren, Germany). A gradient of water and ACN with 0.1% formic acid each was applied for Pe from 5% to 40% ACN in 100 min at 30 °C and for Ue from 5% to 80% ACN in 60 min and to 95% in another 30 min at 30 °C. The flow rate was 0.5 mL/min. The injection volume was about 20 µL. The MS was operated with a capillary voltage of 10 V (ESI+) or -10 V (ESI-), source temperature of 240 °C, and high purity nitrogen as a sheath and auxiliary gas at a flow rate of 80 and 40 (arbitrary units), respectively.
In all measurements, the ions were detected in a mass range of 50–2000 m/z. A collision energy of 35% was used in MS/MS for fragmentation. Data acquisitions and analyses were executed by XcaliburTM 2.0.7 software (Thermo Scientific, Karlsruhe, Germany). For compound determination in Ge, the positive and negative modes were used, and for Pe and Ue only the negative mode.

2.5. DPPH Radical Scavenging Assay

The stable free radical DPPH•, shows a deep violet color in solutions and has a strong absorption at 517 nm. When an odd electron is paired off by an antioxidant, the deep violet color disappears. The decrease in absorption is a measure for antioxidant activity [20]. The procedure was modified from Brand-Williams et al. [21]. In a 96-well plate, 100 μL of 0.2 mM DPPH• in methanol was added to 100 μL serial-diluted plant extracts and allowed to react for 30 min in darkness at ambient temperature. Ascorbic acid and EGCG were used as positive controls. The absorption was read spectrophotometrically at 517 nm with a Tecan Nano Quant infinite M200 PRO Plate Reader (Tecan, Männedorf, Switzerland). Results are expressed as EC50 (the concentration where 50% of the DPPH radical is inhibited). The calculation equation is:
% inhibition = (AB − AE)/AB × 100
where AB and AE are the absorptions in the absence and presence, respectively, of antioxidant substances (plant extracts).

2.6. Assay of Trolox-Equivalent Antioxidant Capacity (TEAC)/ABTS assay

The ABTS radical (ABTS+•) shows a blue-green color and displays absorption at 734 nm. When a pre-formed free radical ABTS+• reacts with electrons donated by an antioxidant, the color and absorption are decreased and compared with that of the standard antioxidant compound Trolox, a water-soluble vitamin E analog [22]. The procedure is according to Pietta et al. [23]. In total, 7 mM ABTS was mixed with 2.45 mM potassium persulfate in de-ionized water and the mixture was put in darkness at ambient temperature for 12–16 h to make the ABTS+• stock solution. The ABTS+• stock solution was diluted with water to obtain the working solution, which should have an absorption of 0.7 (± 0.02) at 734 nm. In 96-well plates, 250 μL of ABTS+• working solution was added to 50 μL serial-diluted plant extracts or Trolox. Trolox (0–40 μM) in 100% ethanol was used to make a standard curve. The plates were incubated at 37 °C in darkness for 6 min and the absorption was read at 734 nm with Tecan Nano Quant infinite M200 PRO Plate Reader. Ascorbic acid and EGCG were used as positive controls. Results were compared with Trolox and expressed as TEAC (Trolox equivalents in mM Trolox/mM test substance).

2.7. Assay of the Ferric Reduction Antioxidant Potential (FRAP)

In the FRAP assay, the trivalent ferric ion complex (Fe3+ - TPTZ) is reduced by reducing agents or antioxidants under acidic conditions, to a complex of divalent ferrous ion (Fe2+ - TPTZ), which shows a blue color and has a peak of absorption at 593 nm [24]. The procedure was performed according to Benzie et al. [25]. Briefly, the FRAP reagent was prepared by mixing 10 mM of TPTZ in 40 mM of hydrogen chloride, 300 mM of acetate buffer (pH 3.6), and 20 mM of ferric chloride in water at a ratio of 1:10:1. In 96-well plates, 175 μL FRAP reagent solution was added to 25 μL serial-diluted substances or ferrous sulfate standards in water. The plates were incubated at 37 °C in darkness for 7 min and the absorption was measured at 593 nm with Tecan Nano Quant infinite M200 PRO Plate Reader. The results are expressed by comparison with the standard ferrous ion to obtain the ferrous equivalent, FE (mmol Fe2+/g test substance).

2.8. Total Phenolic Content Tested by the Folin–Ciocalteu Method

The colorimetric Folin–Ciocalteu method was modified from Swain et al. [26]. The final product from the reaction of the Folin–Ciocalteu method shows a blue color and can be recorded at 750 nm [27]. In total, 100 μL of Folin–Ciocalteu reagent was added to 20 μL of the plant extracts and the standard gallic acid in methanol in a 96-well plate. After 5 min, 80 μL of 7.5% sodium carbonate was added to each well. The plate was allowed to stand in darkness at ambient temperature for 2 h before the absorption was read at 750 nm with Tecan Nano Quant infinite M200 PRO Plate Reader. The standard curve was made with gallic acid (final concentration 0–40 μg/mL). The total phenolic content was compared with gallic acid to obtain the GAE (gallic acid equivalents in mg gallic acid/g test substance).

2.9. Cell Culture and Cytotoxicity Assay

RAW 264.7 cells were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin-streptomycin and 2 mM L-glutamine, and incubated at 37 °C with 5% CO2. The MTT assay was modified from Mosmann [28]. A density of 6 × 104 RAW 264.7 cells was seeded in a 96-well plate and incubated at 37 °C for 24 h. Different concentrations of a substance dissolved in media were added to the cells for an 24 h incubation. The media were removed, and media containing 0.5% MTT were added into every well and further incubated for 2–4 h at 37 °C. Finally, after centrifuging the plate at 400 rpm for 10 min, the absorption was read at 570 nm with the Tecan Nano Quant infinite M200 PRO Plate Reader. The chemotherapeutic agent doxorubicin was used as a positive control.

2.10. Determination of Minimum Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentrations (MBC) by Broth Microdilutions

Broth microdilution was carried out in accordance with CLSI [29]. The plant extract was dissolved in DMSO and then serial diluted with MHB from 10 mg/mL to 0.0048 mg/mL in triplicate in a 96-well plate. The final concentration of DMSO in the test did not exceed 5%. The bacterial suspensions were added to the plate to yield 5 × 105 cfu/mL. The plates were incubated at 37 °C for 20 h. The lowest concentration of plant extract in the well with no visible turbidity was considered the MIC. To determine the minimum bactericidal concentration, 3 μL of suspensions from the clear wells were spread out on an LB agar plate and incubated at 37 °C until sufficient growth was obtained. The lowest concentration that reduced the number of viable cells of the initial inoculum to <0.1% was regarded as the MBC. MHB media, 5% DMSO, ampicillin, ciprofloxacin, and bacterial suspensions were used as controls, respectively.

2.11. Statistical Analysis

Data analysis was carried out with GraphPad Prism 6 (Graphpad Software, San Diego, CA, USA), and SigmaPlot® 11.0 (Systat Software, San Jose, CA, USA). Results were expressed as the mean ± SD. Statistical significance was evaluated using t-test and significance was set at p < 0.05. All experiments were performed independently at least three times.

3. Results

3.1. LC-MS/MS Analysis of Glycyrrhiza glabra Extract

As we can see from Figure 1 and Table 1, several secondary metabolites have been identified by LC-MS/MS analysis from Glycyrrhiza glabra, among which glycyrrhizic acid and (iso)liquiritin apioside isomers are the most abundant compounds.

3.2. LC-MS/MS Analysis of Paeonia lactiflora Extract

As shown in Figure 2 and Table 2, several compounds have been identified in the Paeonia lactiflora extract by LC-MS/MS analysis. Among them, paeoniflorin, galloylpaeoniflorin isomer, probably oxypaeoniflorin, and compounds related to pentagalloyl glucose and to benzoyloxypaeoniflorin are the abundant secondary metabolites.

3.3. LC-MS/MS Analysis of Eriobotrya japonica Extract

As shown in Figure 3 and Table 3, several main compounds (ursolic acid and nerolidol-trirhamnopyranosyl-glucopyranoside or loquatifolin A or 6,7-trans-nerolidol-trirhamnopyranosyl-glucopyranoside, etc.,) have been identified in the Eriobotrya japonica extract by LC-MS/MS analysis.

3.4. Antioxidant Activities and Total Phenolic Contents

The antioxidant activity of the three plant extracts was determined and compared with the known antioxidants ascorbic acid and EGCG. Results are shown in Table 4. The standard curve of Trolox in the ABTS test, ferrous sulfate in FRAP, and gallic acid equivalents in the total phenol test are provided in supplementary Figure S1. The positive control ascorbic acid showed the lowest EC50, i.e., the highest scavenging effect in DPPH assay. Pe had an EC50 value close to ascorbic acid, but slightly higher, meaning it had a slightly weaker antioxidant effect than ascorbic acid; however, this effect was not significant in ABTS and FRAP assays. Ge and Ue did not show stark antioxidant capacity in the three assays. The total phenolic contents analyzed by the Folin–Ciocalteu method are shown as GAE (the phenolic content in 1 g dried sample is equivalent to the amount of gallic acid in mg). The more phenolics in the plant extract, the stronger its antioxidant activity. Pe contained more total phenolics than the Ue and Ge.

3.5. Cytotoxicity

The potential cytotoxicity (IC50 values) of the three plant extracts in RAW 264.7 cells were assessed. The three plant extracts showed concentration-dependent inhibition of cell growth (data not shown), and they were not cytotoxic (with IC50 values between 60 and 100 μg/mL) compared to the positive control doxorubicin and EGCG.

3.6. Antimicrobial Activity

The MIC and MBC of the three plant extracts against two gram-negative (E. coli XL1-Blue MRF′ and Acinetobacter bohemicus) and four gram-positive bacteria (Kocuria kristinae, Micrococcus luteus, Staphylococcus auricularis, and Bacillus megaterium) are presented in Table 5. At the concentrations tested, the three plant extracts varied considerably in their antimicrobial activity against the six bacterial strains. Ue restrained the growth of bacteria at or above 5 or 10 mg/mL. Ge showed intermediate antibacterial activity against all bacterial species (MIC between 0.31 mg/mL and 1.25 mg/mL), except E. coli XL1-Blue MRF′ (MIC > 10 mg/mL). On the other hand, Pe inhibited the growth of Acinetobacter bohemicus, Micrococcus luteus, and Bacillus megaterium at 0.08 mg/mL (Table 5). The control groups (5% DMSO and bacterial suspensions) showed normal bacterial growth, meaning that the solvents did not inhibit bacterial growth in any case.

4. Discussion

Pe has a relatively high DPPH• scavenging activity, which is comparable to that of ascorbic acid. This finding is in agreement with Lee et al. and Bae et al. [47,48]. Ge and Ue extracts were weaker antioxidants in DPPH, ABTS, and FRAP assays. The results of Ge are in agreement with literature data, in which the main plant secondary metabolites (PSMs) liquiritin, glycyrrhizin, and glycyrrhetinic acid did not scavenge the DPPH• or the effects were not strong [49,50,51]. We also tested the effect of glycyrrhizin on scavenging DPPH•, but the effect was negligible (data not shown).
Plant polyphenols usually exhibit good antioxidant properties [11,52,53,54,55]. In detail, the specific structure of polyphenols enables them to donate hydrogen, delocalize electrons, quench singlet oxygen, and react with free radicals [56,57]. E. japonica, the leaves of which contain polyphenols, was found to possess a high degree of antioxidant activity and the radical scavenging activity of its seed extract increased with the polyphenol content [58,59]. The difference of the antioxidant activity of E. japonica between our results and the literature may be due to different solvents of the plant extracts. The three methods used employ different mechanisms, but the reducing capacity of the three plant extracts showed the same trend in the three assays (ascorbic acid or EGCG > Pe > Ue > Ge). Pe contained the most phenolics and therefore showed probably the strongest antioxidant activity.
Our previous study examined the cytotoxicity of the three plant extracts in the drug-resistant cancer cell line CEM/ADR 5000 and Caco-2 compared to the sensitive cancer cell line CCRF-CEM and HCT-116. The three plant extracts did not show strong cytotoxicity compared to the positive control doxorubicin in sensitive and resistant cell lines [16]. This time, we showed that the three plant extracts were not cytotoxic against a murine macrophage RAW 264.7 cell line, either. These results verify that the traditional usage of these plants is safe and pave the way for their future usage.
Plant extracts and essential oils have been widely studied and used as antimicrobial agents in the last decades [11,60]. The MBC of the three plant extracts is usually two to four times that of MIC, suggesting a dose-dependent effect on bacteria. The ratio of some MBC to MIC is >4, suggesting the bacteriostatic effect of the plant extracts on the bacteria. Few antimicrobial studies of the leaf extract of E. japonica have been conducted and it did not show toxicity against the six bacterial strains here. The G. glabra extract showed antimicrobial activity in some other bacterial strains [61,62,63,64,65] and medium effect against five bacterial strains in this study. The P. lactiflora extract was reported to exhibit antibacterial and antiviral activity [66,67]; its antibacterial effect was strong on some bacteria species here. The secondary metabolites in plants, such as saponins, phenolic compounds (e.g., flavonoids or tannins), essential oils, and monoterpenes, contribute to their antimicrobial capacity [11,68,69,70]. Wang reviewed the finding that one triterpene (18β-glycyrrhetinic acid) and four flavonoids (licochalcone A, licochalcone E, glabridin, and liquiritigenin) underlie the antimicrobial activity in G. glabra [71]. Low concentrations of the PSMs in G. glabra, such as glycyrrhizic acid, 18β-glycyrrhetinic acid, liquiritigenin, and isoliquiritigenin, were also tested in the six species, but the effect was not significant (data not shown), suggesting that these PSMs did not contribute to the medium antibacterial activity of G. glabra. However, polyphenols can interact with proteins in cells, because they possess several phenolic OH groups, which allow them to make hydrogen and ionic bonds with amino groups in proteins. When important bacterial proteins are affected, an antimicrobial effect can occur [72]. The strong antibacterial effect of Pe was probably due to its phenolic content. Correspondingly, the same principle might also explain the antibacterial activity of Ge and Ue. The mechanism of antimicrobial activity of P. lactiflora root and E. japonica leaves was reported to be disruption of protein and cell-wall synthesis [73]. More studies are needed to elucidate the potential of the three plant extracts as antimicrobial agents and the possible mechanisms.

5. Conclusions

Our results show that the three extracts of TCM plants are low-toxic, but biologically active, which would explain their wide usage in traditional medicine. Especially Pe and Ge, should be studied further for their potential to be developed as antioxidant food supplements or antibacterial drugs.

Supplementary Materials

The following are available online at https://www.mdpi.com/2305-6320/6/2/43/s1, Figure S1: The standard curves in the TEAC, FRAP, and Folin–Ciocateu assays shown as absorption vs. concentration, Table S1: Secondary metabolites in Glycyrrhiza glabra, Table S2: Secondary metabolites in Peonia lactiflora, Table S3: Secondary metabolites in Paeonia veitchii, Table S4: Secondary metabolites in Eriobotrya japonica.

Author Contributions

Conceptualization, J.-X.Z. and M.W.; methodology, J.-X.Z., M.S.B., P.W., and B.W.; writing—original draft preparation, J.-X.Z., P.W., and B.W.; writing—review and editing, J.-X.Z., M.S.B., P.W., B.W., and M.W. Supervision, M.W.

Funding

We acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Württemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universität Heidelberg.

Acknowledgments

We kindly thank Mariana Roxo for introducing J.-X.Z. to the antioxidant assay methods. We also thank Douglas Fear for checking the English.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gao, Z. Artemisinin anti-malarial drugs in China. Acta Pharm. Sin. B 2016, 6, 115–124. [Google Scholar] [CrossRef] [Green Version]
  2. Chan, S.; Li, S.; Kwok, C.; Benzie, I.; Szeto, Y.; Guo, D.; He, X.; Yu, P. Antioxidant activity of Chinese medicinal herbs. Pharm. Biol. 2008, 46, 587–595. [Google Scholar] [CrossRef]
  3. Liao, H.; Banbury, L.K.; Leach, D.N. Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics. Evid. Based Complement. Alternat. Med. 2008, 5, 429–434. [Google Scholar] [CrossRef]
  4. Kaushik, A.; Jijta, C.; Kaushik, J.J.; Zeray, R.; Ambesajir, A.; Beyene, L. FRAP (Ferric reducing ability of plasma) assay and effect of Diplazium esculentum (Retz) Sw. (a green vegetable of North India) on central nervous system. Indian J. Nat. Prod. Resour. 2012, 3, 228–231. [Google Scholar]
  5. Dudonné, S.; Vitrac, X.; Coutière, P.; Woillez, M.; Mérillon, J. Comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD, and ORAC Assays. J. Agric. Food Chem. 2009, 57, 1768–1774. [Google Scholar] [CrossRef]
  6. Antolovich, M.; Prenzler, P.D.; Patsalides, E.; McDonald, S.; Robards, K. Methods for testing antioxidant activity. Analyst 2002, 127, 183–198. [Google Scholar] [CrossRef]
  7. Gutteridge, J.M.C. Biological origin of free radicals, and mechanisms of antioxidant protection. Chem. Biol. Interact. 1994, 91, 133–140. [Google Scholar] [CrossRef]
  8. Irshad, Md.; Zafaryab, Md.; Singh, M.; Rizvi, M.M.A. Comparative analysis of the antioxidant activity of Cassia fistula extracts. Int. J. Med. Chem. 2012, 2012, 157125. [Google Scholar] [CrossRef]
  9. Mambro, V.M.D.; Fonseca, M.J.V. Assays of physical stability and antioxidant activity of a topical formulation added with different plant extracts. J. Pharm. Biomed. Anal. 2005, 37, 287–295. [Google Scholar] [CrossRef]
  10. Vaya, J.; Belinky, P.A.; Aviram, M. Antioxidant constituents from licorice roots: Isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic. Biol. Med. 1997, 23, 302–313. [Google Scholar] [CrossRef]
  11. Van Wyk, B.E.; Wink, M. Medicinal Plants of the World, 2nd ed.; Briza: Pretoria, South Africa, 2017. [Google Scholar]
  12. Shibata, S. A drug over the millennia: Pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 2000, 120, 849–862. [Google Scholar] [CrossRef] [PubMed]
  13. Fiore, C.; Eisenhut, M.; Ragazzi, E.; Zanchin, G.; Armanini, D. A history of the therapeutic use of liquorice in Europe. J. Ethnopharmacol. 2005, 99, 317–324. [Google Scholar] [CrossRef]
  14. Wang, W.; Wang, C.; Gu, S.; Cao, Q.; Lv, Y.; Gao, J.; Wang, S. Pharmacokinetic studies of the significance of herbaceous compatibility of peony liquorice decoction. World Sci. Technol. 2009, 11, 382–387. [Google Scholar] [CrossRef]
  15. Zhang, B.; Liu, Q. Experimental study on the prescription of Shaoyao Gancao Decoction. Chin. Tradit. Pat. Med. 2012, 34, 1354–1358. (In Chinese) [Google Scholar]
  16. Zhou, J.; Wink, M. Reversal of multidrug resistance in human colon cancer and human leukemia cells by three plant extracts and their major secondary metabolites. Medicines 2018, 5, 123. [Google Scholar] [CrossRef]
  17. Duan, T.; Yu, M.; Liu, C.; Ma, C.; Wang, W.; Wei, S. Simultaneous determination of glycyrrhizic acid, liquiritin and fingerprint of licorice by RP-HPLC. Chin. Tradit. Pat. Med. 2006, 28, 161–165. (In Chinese) [Google Scholar]
  18. Yu, D.; Gu, X.; Zhang, C.; Chen, C.; Ma, Y. Comparison of different extracting processes for paeoniflorin in Paeoniae Radix Alba. Chin. J. Exp. Tradit. Med. Formul. 2013, 19, 49–51. [Google Scholar]
  19. Xiang, Y.; Yang, X.; Yang, G.; Huang, W. Extraction and isolation of ursolic acid from the leaves of Eriobotrya japonica. Herald Med. 2005, 12, 1105–1106. (In Chinese) [Google Scholar]
  20. Blois, M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
  21. Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. Lebensmittel-Wissenschaft und -Technologie 1995, 28, 25–30. [Google Scholar] [CrossRef]
  22. Miller, N.J.; Rice-Evans, C.A. Factors influencing the antioxidant activity determined by the ABTS radical cation assay. Free Radic. Res. 1996, 26, 195–199. [Google Scholar] [CrossRef]
  23. Pietta, P.; Simonetti, P.; Gardana, C.; Mauri, P. Trolox equivalent antioxidant capacity (TEAC) of Ginkgo biloba flavonol and Camellia sinensis catechin metabolites. J. Pharm. Biomed. Anal. 2000, 23, 223–226. [Google Scholar] [CrossRef]
  24. Liu, T.Z.; Chin, N.; Kiser, M.D.; Bigler, W.N. Specific spectrophotometry of ascorbic acid in serum or plasma by use of ascorbate oxidase. Clin. Chem. 1982, 28, 2225–2228. [Google Scholar]
  25. Benzie, I.F.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal. Biomed. 1996, 239, 70–76. [Google Scholar] [CrossRef]
  26. Swain, T.; Hillis, W.E. The phenolic constituents of Prunus domestica. J. Sci. Food Agric. 1959, 10, 63–68. [Google Scholar] [CrossRef]
  27. Singleton, V.L.; Orthofer, R.; Lamuela-Raventós, R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999, 299, 152–178. [Google Scholar] [CrossRef]
  28. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
  29. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 9th ed.; CLSI document M07-A9; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2012. [Google Scholar]
  30. Farag, M.A.; Porzel, A.; Wessjohann, L.A. Comparative metabolite profiling and fingerprinting of medicinal licorice roots using a multiplex approach of GC-MS, LC-MS and 1D NMR techniques. Phytochemistry 2012, 76, 60–72. [Google Scholar] [CrossRef]
  31. Ye, Z.; Dai, J.; Zhang, C.; Lu, Y.; Wu, L.; Gong, A.G.W.; Xu, H.; Tsim, K.W.K.; Wang, Z. Chemical differentiation of Dendrobium officinale and Dendrobium devonianum by using HPLC fingerprints, HPLC-ESI-MS, and HPTLC analyses. Evid. Based Complement. Alternat. Med. 2017. [Google Scholar] [CrossRef]
  32. Link, P.; Wetterauer, B.; Fu, Y.; Wink, M. Extracts of Glycyrrhiza uralensis and isoliquiritigenin counteract amyloid-β toxicity in Caenorhabditis elegans. Planta Med. 2015, 81, 357–362. [Google Scholar] [CrossRef]
  33. Montoro, P.; Maldini, M.; Russo, M.; Postorino, S.; Piacente, S.; Pizza, C. Metabolic profiling of roots of liquorice (Glycyrrhiza glabra) from different geographical areas by ESI/MS/MS and determination of major metabolites by LC-ESI/MS and LC-ESI/MS/MS. J. Pharm. Biomed. Anal. 2011, 54, 535–544. [Google Scholar] [CrossRef]
  34. Song, R.; Xu, L.; Zhang, Z.; Tian, Y.; Xu, F.; Dong, H. Determination of gallic acid in rat plasma by LC-MS-MS. Chroma 2010, 71, 1107–1111. [Google Scholar] [CrossRef]
  35. Niu, Y.; Wang, S. Analysis on chemical constituents in Danggui-Shaoyao-San by LC-Q-TOF-MS and LC-IT-MSn. Chin. Tradit. Herb. Drugs 2014, 45, 1056–1062. (In Chinese) [Google Scholar] [CrossRef]
  36. Li, F.; Zhang, B.; Wei, X.; Song, C.; Qiao, M.; Zhang, H. Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MSn. Mol. Med. Rep. 2016, 13, 4191–4204. [Google Scholar] [CrossRef]
  37. Wu, X.; Wu, M.; Chen, X.; Zhang, H.; Ding, L.; Tian, F.; Fu, X.; Qiu, F.; Zhang, D. Rapid characterization of the absorbed chemical constituents of Tangzhiqing formula following oral administration using UHPLC-Q-TOF-MS. J. Sep. Sci. 2018, 41, 1025–1038. [Google Scholar] [CrossRef]
  38. Ye, M.; Liu, S.; Jiang, Z.; Lee, Y.; Tilton, R.; Cheng, Y. Liquid chromatography/mass spectrometry analysis of PHY906, a Chinese medicine formulation for cancer therapy. Rapid Commun. Mass Spectrom. 2007, 21, 3593–3607. [Google Scholar] [CrossRef]
  39. Shi, Y. Chemical constituents with anti-allergic activity from red peony root and a horticultural cultivar of Paeonia lactiflora and monoterpenoids profiles of peony related species. Ph.D. Thesis, University of Toyama, Toyama, Japan, March 2016. [Google Scholar]
  40. Dong, H.; Liu, Z.; Song, F.; Yu, Z.; Li, H.; Liu, S. Structural analysis of monoterpene glycosides extracted from Paeonia lactiflora Pall. using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2007, 21, 3193–3199. [Google Scholar] [CrossRef]
  41. Gao, J.; Zhang, J.; Qu, Z.; Zhou, H.; Tong, Y.; Liu, D.; Yang, H.; Gao, W. Study on the mechanisms of the bronchodilator effects of Folium Eriobotryae and the selected active ingredient on isolated gunea pig tracheal strips. Pharm. Biol. 2016, 54, 2742–2752. [Google Scholar] [CrossRef]
  42. Zhou, C.; Liu, Y.; Su, D.; Gao, G.; Zhou, X.; Sun, L.; Ba, X.; Chen, X.; Bi, K. A sensitive LC-MS-MS method for simultaneous quantification of two structural isomers, hyperoside and isoquercitrin: Application to pharmacokinetic studies. Chroma 2011, 73, 353–359. [Google Scholar] [CrossRef]
  43. Lin, Y.; Xu, W.; Huang, M.; Xu, W.; Li, H.; Ye, M.; Zhang, X.; Chu, K. Qualitative and quantitative analysis of phenolic acids, flavonoids and iridoid glycosides in yinhua kanggan tablet by UPLC-QqQ-MS/MS. Molecules 2015, 20, 12209–12228. [Google Scholar] [CrossRef]
  44. Zhao, L.; Chen, J.; Yin, M.; Ren, B.; Li, W. Analysis of sesquiterpene glycosides from loquat leaves by UPLC-Q-TOF-MS. Chin. Tradit. Pat. Med. 2015, 37, 1498–1502. (In Chinese) [Google Scholar]
  45. De Tommasi, N.; Aquino, R.; De Simone, F.; Pizza, C. Plant metabolites. New sesquiterpene and ionone glycosides from Eriobotrya japonica. J. Nat. Prod. 1992, 55, 1025–1032. [Google Scholar] [CrossRef]
  46. Wu, L.; Jiang, X.; Huang, L.; Chen, S. Processing technology investigation of loquat (Eriobotrya japonica) leaf by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry combined with chemometrics. PLoS ONE 2013, 8, e64178. [Google Scholar] [CrossRef]
  47. Lee, C.; Kwon, Y.S.; Son, K.H.; Kim, H.P.; Heo, M.Y. Antioxidative constituents from Paeonia lactiflora. Arch. Pharm. Res. 2005, 28, 775–783. [Google Scholar] [CrossRef] [PubMed]
  48. Bae, J.; Kim, C.Y.; Kim, H.J.; Park, J.H.; Ahn, M. Differences in the chemical profiles and biological activities of Paeonia lactiflora and Paeonia obovata. J. Med. Food 2015, 18, 224–232. [Google Scholar] [CrossRef]
  49. Cheel, J.; Antwerpen, P.V.; Tumová, L.; Onofre, G.; Vokurková, D.; Zouaoui-Boudjeltia, K.; Vanhaeverbeek, M.; Nève, J. Free radical-scavenging, antioxidant and immunostimulating effects of a licorice infusion (Glycyrrhiza glabra L.). Food Chem. 2010, 122, 508–517. [Google Scholar] [CrossRef]
  50. Kato, T.; Horie, N.; Hashimoto, K.; Satoh, K.; Shimoyama, T.; Kaneko, T.; Kusama, K.; Sakagami, H. Bimodal effect of glycyrrhizin on macrophage nitric oxide and prostaglandin E2 production. In Vivo 2008, 22, 583–586. [Google Scholar] [PubMed]
  51. Imai, K.; Takagi, Y.; Iwazaki, A.; Nakanishi, K. Radical scavenging ability of glycyrrhizin. Free Radic. Antioxid. 2013, 3, 40–42. [Google Scholar] [CrossRef] [Green Version]
  52. Bors, W.; Michel, C. Chemistry of the antioxidant effect of polyphenols. Ann. N. Y. Acad. Sci. 2002, 957, 57–69. [Google Scholar] [CrossRef] [PubMed]
  53. Zahin, M.; Aqil, F.; Ahmad, I. The in vitro antioxidant activity and total phenolic content of four Indian medicinal plants. J. Pharm. Pharm. Sci. 2009, 1, 88–95. [Google Scholar]
  54. Li, X.; Wu, X.; Huang, L. Correlation between antioxidant activities and phenolic contents of radix Angelicae sinensis (Danggui). Molecules 2009, 14, 5349–5361. [Google Scholar] [CrossRef] [PubMed]
  55. Tosun, M.; Ercisli, S.; Sengul, M.; Ozer, H.; Polat, T.; Ozturk, E. Antioxidant properties and total phenolic content of eight Salvia species from Turkey. Biol. Res. 2009, 42, 175–181. [Google Scholar] [CrossRef] [PubMed]
  56. Proestos, C.; Lytoudi, K.; Mavromelanidou, O.K.; Zoumpoulakis, P.; Sinanoglou, V.J. Antioxidant capacity of selected plant extracts and their essential oils. Antioxidants 2013, 2, 11–22. [Google Scholar] [CrossRef] [PubMed]
  57. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20, 933–956. [Google Scholar] [CrossRef]
  58. Song, F.; Gan, R.; Zhang, Y.; Xiao, Q.; Kuang, L.; Li, H.B. Total phenolic contents and antioxidant capacities of selected Chinese medicinal plants. Int. J. Mol. Sci. 2010, 11, 2362–2372. [Google Scholar] [CrossRef]
  59. Yokota, J.; Takuma, D.; Hamada, A.; Onogawa, M.; Yoshioka, S.; Kusunose, M.; Miyamura, M.; Kyotani, S.; Nishioka, Y. Scavenging of reactive oxygen species by Eriobotrya japonica seed extract. Biol. Pharm. Bull. 2006, 29, 467–471. [Google Scholar] [CrossRef]
  60. Hamoud, R.; Sporer, F.; Reichling, J.; Wink, M. Antimicrobial activity of a traditionally used complex essential oil distillate (Olbas® Tropfen) in comparison to its individual essential oil ingredients. Phytomedicine 2012, 19, 969–976. [Google Scholar] [CrossRef]
  61. Gupta, V.K.; Fatima, A.; Faridi, U.; Negi, A.S.; Shanker, K.; Kumar, J.K.; Rahuja, N.; Luqman, S.; Sisodia, B.S.; Saikia, D.; et al. Antimicrobial potential of Glycyrrhiza glabra roots. J. Ethnopharmacol. 2008, 116, 377–380. [Google Scholar] [CrossRef]
  62. Sedighinia, F.; Afshar, A.S.; Soleimanpour, S.; Zarif, R.; Asili, J.; Ghazvini, K. Antibacterial activity of Glycyrrhiza glabra against oral pathogens: An in vitro study. Avicenna J. Phytomed. 2012, 2, 118–124. [Google Scholar]
  63. Geetha, R.V.; Roy, A. In Vitro evaluation of antibacterial activity of ethanolic root extract of Glycyrrhiza glabra on oral microbes. Int. J. Drug Dev. Res. 2012, 4, 161–165. [Google Scholar]
  64. Aggarwal, H.; Ghosh, J.; Rao, A.; Chhokar, V. Evaluation of root and leaf extracts of Glycyrrhiza glabra for antimicrobial activity. J. Med.Bioeng. 2015, 4, 81–85. [Google Scholar]
  65. Nitalikar, M.M.; Munde, K.C.; Dhore, B.V.; Shikalgar, S.N. Studies of antibacterial activities of Glycyrrhiza glabra root extract. Int. J. PharmTech. Res. 2010, 2, 899–901. [Google Scholar]
  66. Park, K.; Cho, S. Antimicrobial characteristics of Paeonia lactiflora Pall. extract tested against food-putrefactive microorganisms. Korean J. Food Preserv. 2010, 17, 706–711. [Google Scholar]
  67. Boo, K.; Lee, D.; Woo, J.; Ko, S.H.; Jeong, E.; Hong, Q.; Riu, K.Z.; Lee, D. Anti-bacterial and anti-viral activity of extracts from Paeonia lactiflora roots. J. Korean Soc. Appl. Biol. Chem. 2011, 54, 132–135. [Google Scholar] [CrossRef]
  68. Dhanya, K.N.M.; Sidhu, P. The antimicrobial activity of Azardirachta indica, Glycyrrhiza glabra, Cinnamum zeylanicum, Syzygium aromaticum, Accacia nilotica on Streptococcus mutans and Enterococcus faecalis—An in vitro study. Endodontology 2011, 23, 18–25. [Google Scholar]
  69. Sharopov, F.; Braun, M.S.; Gulmurodov, I.; Khalifaev, D.; Isupov, S.; Wink, M. Antimicrobial, antioxidant, and anti-inflammatory activities of essential oils of selected aromatic plants from Tajikistan. Foods 2015, 4, 645–653. [Google Scholar] [CrossRef]
  70. Youssef, F.S.; Hamoud, R.; Ashour, M.L.; Singab, A.N.; Wink, M. Volatile oils from the aerial parts of Eremophila maculata and their antimicrobial activity. Chem. Biodivers. 2014, 11, 831–841. [Google Scholar] [CrossRef]
  71. Wang, L.; Yang, R.; Yuan, B.; Liu, Y.; Liu, C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm. Sin. B 2015, 5, 310–315. [Google Scholar] [CrossRef] [Green Version]
  72. Wink, M. Modes of action of herbal medicines and plant secondary metabolites. Medicines 2015, 2, 251–286. [Google Scholar] [CrossRef] [PubMed]
  73. Viswanad, V.; Aleykutty, N.A.; Zachariah, S.M.; Prabhakar, V. Antimicrobial potential of herbal medicines. Int. J. Pharm. Sci. Res. 2011, 2, 1651–1658. [Google Scholar]
Medicines 06 00043 g001 550
Figure 1. The photodiode array chromatogram (PDA) (a) and the total ion current (TIC) (b) of the G. glabra extract. The compounds listed in Table 1 correspond to the retention times of the TIC.
Figure 1. The photodiode array chromatogram (PDA) (a) and the total ion current (TIC) (b) of the G. glabra extract. The compounds listed in Table 1 correspond to the retention times of the TIC.
Medicines 06 00043 g001
Medicines 06 00043 g002 550
Figure 2. The photodiode array chromatogram (PDA) (a) and the total ion current (TIC) (b) of the P. lactiflora extract. The compounds listed in Table 2 correspond to the retention times of the TIC.
Figure 2. The photodiode array chromatogram (PDA) (a) and the total ion current (TIC) (b) of the P. lactiflora extract. The compounds listed in Table 2 correspond to the retention times of the TIC.
Medicines 06 00043 g002
Medicines 06 00043 g003 550
Figure 3. The photodiode array chromatogram (PDA) (a) and the total ion current (TIC) (b) of the E. japonica. The compounds listed in Table 3 correspond to the retention times of the TIC.
Figure 3. The photodiode array chromatogram (PDA) (a) and the total ion current (TIC) (b) of the E. japonica. The compounds listed in Table 3 correspond to the retention times of the TIC.
Medicines 06 00043 g003
Table
Table 1. Retention times (RT), MS data, and tentatively identified compounds in the G. glabra extract.
Table 1. Retention times (RT), MS data, and tentatively identified compounds in the G. glabra extract.
RT (min)[M-H]− (m/z)MS/MS (m/z) from [M-H]−[M-H]+ m/zMS/MS (m/z) from [M+H]+PDA λmax [nm]Tentative IdentificationReferences
2.78563.29353.19; 443.13; 473.12; 503.16565.07409.11; 427.05; 445.06; 457.03; 481.05; 499.03; 511.04; 528.96; 546.95217; 274; 334rhamnoliquiritin[30]
3.39577.31353.21; 383.21; 439.18; 457.14; 473.19; 503.09; 559.26579.18423.07; 441.03; 525.04; 542.95; 560.91217; 272; 331isoviolanthin[30,31]
3.78549.59255.12; 297.14; 429.11551.11388.11217; 270; 314liquiritin apioside isomer[30,32]
257.21136.97; 146.94; 238.98 source fragment
419.13256.94; 296.73; 364.73; 399.87 source fragment
3.99549.43255.09; 297.17; 417.23; 429.12551.16313.29; 388.11227; 276; 311liquiritin apioside isomer[30,32]
419.05257.01 source fragment
257.21136.96; 147.03; 238.97 source fragment
4.28417.26n.d.418.94257.01217; 276; 309liquiritin[30,32]
257.17136.96; 147.03; 238.97 source fragment
5.86549.43n.d.551.13n.d.219; 360isoliquiritin apioside isomer[30,32]
6.05549.36n.d.551.14n.d.220; 365; 380isoliquiritin apioside isomer[30,32]
6.28695.42531.22; 549.17431.13269.10218; 262; 307licorice glycoside isomer[30]
6.51695.33531.18; 549.18697.26668.04220; 282; 316licorice glycoside isomer[30]
725.29255.32; 416.95; 531.21; 549.18727.21549.09; 726.16 licorice glycoside isomer[30]
6.59417.16255.09419.15257.01217; 297; 371isoliquiritin[30,32]
7.54983.63820.91985.43n.d.216licorice saponin A3[30,32,33]
7.78695.30n.d.697.1516.49218; 325; 362licorice glycoside isomer[30]
725.28n.d.727.03549.09; 726.16 licorice glycoside isomer[30]
9.49837.52530.89; 661.45839.24663.02; 761.61215licorice saponin G2[30,32,33]
1675.47837.42-- dimer
10.25821.75351.07; 759.49823.31n.d.217; 250glycyrrhizic acid[30,32,33]
1643.72821.61645.69n.d. dimer
10.91821.67n.d.823.31n.d.217; 245probably saponinpers. com. PW
11.19821.54351.12823.13n.d.216; 369probably saponinpers. com. PW
11.59822.91351.06; 646.57; 803.97825.15n.d.216licorice saponin J2[30,32,33]
16.17407.15n.d.409.07203.03; 204.98; 247.05; 363.06; 391.00217; 2803-hydroxyglabrol[30]
17.81391.28n.d.393.08204.97; 337.00216; 282glabrol[30]
782.92n.d. dimer
n.d. not detectable. Fragments shown in bold are the main fragments.
Table
Table 2. Retention times (RT), MS data, and tentatively identified compounds in the P. lactiflora extract.
Table 2. Retention times (RT), MS data, and tentatively identified compounds in the P. lactiflora extract.
RT (min)[M-H]− (m/z)MS/MS (m/z)PDA λmax (nm)Tentative IdentificationReferences
4.63169.11125.22; 126.38; 169.12250gallic acid[34]
338.62169.12; 253.11; 291.91; 320.43; 339.05 gallic acid [2M-CO2-H]−pers. com. BW
6.27493.26*169.18; 241.14; 283.26; 313.13; 331.04; 403.13230; 273galloylsucrose isomer[35]
986.96Nl
6.97493.24*211.22; 271.12; 313.16; 331.04; 384.22; 433.14; 475.58230; 273galloylsucrose isomer[35]
986.98Nl
7.32493.19*169.25; 271.45; 313.17; 331.04; 389.98; 449.02230; 274galloylsucrose isomer[35]
986.88Nl
9.68483.19150.90; 169.14; 193.34; 223.18; 271.10; 295.22; 313.12; 331.11; 426.15230; 273digalloyl glucose[36]
21.17495.22177.12; 299.13; 333.19; 387.11; 447;06; 465.17; 477.11227; 253probably oxypaeoniflorin[37]
27.50525.03196.34; 213.42; 283.35; 317.24; 357.38; 391.56; 435.70; 475.77; 479.07; 524.58221; 237; 273albiflorin[38]
29.28197.17124.32; 141.56; 153.01; 169.18; 197.16231; 272probably ethyl gallate[36]
394.72-
30.14635.1207.31; 234.79; 313.09; 358.75; 465.13; 483.14; 524.23; 566.84; 589.17233; 276trigalloyl glucose[36]
30.53449.04165.01; 179.34; 205.10; 261.31; 282.87; 309.03; 326.95; 398.60; 431.13243; 274peaoniflorin [M-CH2O-H]−Standard
479.04149.09; 177,10; 248.83; 267.08; 309.08; 326.98; 355.61; 356.96; 432.93; 449.16; 460.71; 477.94 paeoniflorin [M-H]−[36,39]
525.01176.88; 282.89; 327.09; 356.85; 449.01; 476.31; 478.83; 494.01; 506.96 paeoniflorin [M+HCOOH-H]−[37,38]
32.08463.24301.30; 343.04; 394.94; 445.33; 463.25253; 361; 280visculdulin I 2´-glycoside[38]
39.69787.17**295.17; 447.22; 465.33; 483.29; 617.32; 635.17232; 277probably tetragalloyl glucose isomer[36]
40.29611.22301.30; 343.35; 385.33; 427.35; 445.21232; 272
40.93477.22160.70; 300.45; 315.12; 357.02; 408.88227; 253; 360probably related to isorhamnetin 7-O-glucoside[36]
41.36301.31145.14; 185.44; 229.47; 257.47; 301.33249; 367
509.10202.99; 254.25; 314.06; 372.80; 440.82; 463.22; 480.12
787.13**295.23; 403.40; 465.43; 530.46; 573.46; 617.18; 635.14; 679.31; 719.88 probably tetragalloyl glucose isomer[36]
42.74631.25271.16; 313.23; 399.30; 465.30; 479.28; 491.23; 509.22; 585.17; 613.18234; 274gallylpaeoniflorin isomer[35,36,37,39,40]
47.77939.11277.04; 341.21; 385.21; 447.13; 511.35; 573.25; 599.15; 617.19; 725.13; 769.12; 787.03234; 269probably related to pentagalloyl glucose[36]
48.49615.18239.29; 263.04; 281.22; 401.27; 431.23; 447.22; 459.26; 477.22; 495.21; 567.13; 585.16; 597.17232; 275mudanpioside H[36]
61.98599.26241.29; 281.46; 333.31; 385.39; 403.06; 429.22; 447.51; 459.42; 477.31; 569.17; 581,12233; 274probably related to benzoyloxypaeoniflorin[39]
1394.92599.23; 937.97; 970.98; 1090.82; 1126.36; 1165.39; 1241.78; 1257.75; 1309.67; 1318.90; 1336.64
73.24628.99552.66; 582.88239; 274probably related to benzoylpaeoniflorin[37,39]
1212.42876.29; 1067.88
* isomers; ** related; nl: neutral loss. Fragments shown in bold are the main fragments.
Table
Table 3. Retention times (RT), MS data, and tentatively identified compounds in the E. japonica extract.
Table 3. Retention times (RT), MS data, and tentatively identified compounds in the E. japonica extract.
RT (min)[M-H]− (m/z)MS/MS (m/z)PDA λmax (nm)Tentative IdentificationReferences
11.05352.96110.40; 143.67; 179.20; 191.20; 284.50; 312.26234; 295; 325probably chlorogenic acid[41]
420.95259.61; 301.23; 331.19; 343.20; 352.64; 360.36; 375.14; 385.20; 392.55; 403.15 n.c.
17.18 (16.48–17.26)463.17151.00; 179.09; 190.34; 221.17; 255.30; 271.50; 300.25; 301.16; 325.03; 343.10; 373.35; 400.93; 418.54; 445.14234; 347hyperoside or isoquercetin isomers[42,43]
547.19220.44; 292.64; 310.81; 384.91; 437.90; 478.82; 500.58; 515.88 n.c.
593.04255.34; 284.19; 327.19; 411.21; 429.21; 447.18; 473.09; 565.32 n.c.
855.43417.31; 545.16; 563.31; 691.43; 709.34; 735.38; 864.27 n.c.
901.14299.82; 439.19; 610.71; 721.14; 763.80; 854.33; 914.59 n.c.
28.12821.37511.74; 529.60; 657.60; 675.39; 721.14; 766.16221; 234; 280(trans)nerolidol-trirhamnopyranosyl-glucopyranoside or loquatifolin A [44] (compound 1 or 4)
867.12596.27; 675.92; 690.31; 721.42; 740.66; 786.99; 815.64; 820.05; 833.88 n.c.
1688.98551.69; 696.87; 719.35; 821.28; 865.28; 881.05; 1275.89; 1396.00; 1541.66 n.c.
29.11807.37529.33; 661.43; 675.31217; 234; 280unknown new compound[44](compound 2)
853.02350.34; 454.48; 503.33; 649.33; 731.12; 784.53; 809.49; 839.42; 853.53 n.c.
31.52675.31204.97; 307.09; 383.17; 467.33; 529.20; 574.81221; 234; 283; 312nerolidol-dirhamnopyranosyl-glucopyranoside[44] (compound 3 or 5)
721.21490.37; 597.16; 675.29 [M+HCOO-H]− of 675.31 [M-H]−[44]
33.12-33.67967.47309.10; 351.25; 395.15;437.27; 511.25; 529.48; 579.22; 639.41; 657.34; 675.47; 717.98; 743.29; 761.35; 803.44; 821.38; 848.32; 865.41; 922.75; 945.31334; 289; 323n.c.
997.51381.23; 467.03; 511.14; 529.05; 543.22; 567.25; 603.04; 657.15; 675.18; 697.48; 721.08; 773.26; 803.34; 821.36; 833.47; 915.25; 938.24 probably nerolidol--rhamnopyranosyl -rhamnopyranosyl--(4-trans-feruloyl)-rhamnopyranosyl--glucopyranoside[45]
1065.21405.44; 513.91; 579.73; 675.96; 1020.72; 1033.32; 1041.27; 1057.41; 1067.28 n.c.
50.02633.52339.61; 469.47; 487.39; 513.48; 571.44; 589.50; 615.47; 633.50219; 235; 310probably 3-O-p-coumaroyltormetic acid[46]
1267.271102.55 n.c.
62.90523.39-219; 235; 281Usolic acid (monomer adduct)*Standard
933.70408.37; 455.50; 500.98; 584.57; 745.53; 870.99; 933.70 Usolic acid [2M + Na+ -2H+]−Standard
1411.83455.52; 501.44; 933.71; 1302.93; 1377.25; 1410.15 Usolic acid [3M + 2Na+ -3H+]−Standard
1885.16934.78; 1391.11; 1406.28; 1447.24; 1608.90; 1743.24; 1855.24 Usolic acid [4M + 3Na+ -4H+]−Standard
All further mass peaks were assumed to be chlorophyll related, because of absorption maxima of 408 nm and higher. n.c.: not classifiable. Fragments shown in bold are the main fragments.* Ursolic acid shows, instead of its monomer ion (m/z 455.50 [M-H+]−), an unknown adduct combination (X) with m/z 523.39 [M+X-H+]− and forms additional dimer, trimer, and tetramer adducts with Na+ ions.
Table
Table 4. The in vitro antioxidant capacity and total phenolic content of the plant extracts.
Table 4. The in vitro antioxidant capacity and total phenolic content of the plant extracts.
Plant ExtractsDPPH EC50 (μg/mL)TEAC (mM Trolox/mM)FE (mmol Fe2+/g)GAE (mg gallic acid/g)
Ascorbic acid2.31 ± 0.016363.67 ± 32.3714,268.44 ± 66.18-
EGCG9.20 ± 1.1815,708.35 ± 54.7225,318.57 ± 114.83-
Glycyrrhiza glabra extract116.17 ± 0.55672.19 ± 5.06477.42 ± 13.0034.19 ± 2.07
Paeonia lactiflora extract5.15 ± 0.052567.26 ± 32.833504.07 ± 51.07323.19 ± 10.19
Eriobotrya japonica extract35.50 ± 1.99758.63 ± 5.231464.28 ± 8.32131.32 ± 12.33
-: not tested; TEAC: Trolox equivalents in mM Trolox/mM test substance; FE: ferrous equivalents in mmol Fe2+/g test substance; GAE: gallic acid equivalents in mg gallic acid/g test substance.
Table
Table 5. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the three plant extracts.
Table 5. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the three plant extracts.
BacteriaMIC
MBC		Ampicillin (μg/mL)Ciprofloxacin (μg/mL)Glycyrrhiza glabra Extract (mg/mL)Paeonia lactiflora Extract (mg/mL)Eriobotrya japonica Extract (mg/mL)
E. coli XL1-Blue MRF′MIC80.03>102.510
MBC160.06-5-
Acinetobacter bohemicusMIC20.031.250.085
MBC80.052.51.2510
Kocuria kristinaeMIC0.130.130.631.25>10
MBC0.250.51.252.5-
Micrococcus luteusMIC0.250.50.310.0810
MBC221.250.63-
Staphylococcus auricularisMIC0.50.060.631.255
MBC40.131.25>1010
Bacillus megateriumMIC0.250.060.310.0810
MBC10.130.630.31-
-: not detectable.

Share and Cite

MDPI and ACS Style

Zhou, J.-X.; Braun, M.S.; Wetterauer, P.; Wetterauer, B.; Wink, M. Antioxidant, Cytotoxic, and Antimicrobial Activities of Glycyrrhiza glabra L., Paeonia lactiflora Pall., and Eriobotrya japonica (Thunb.) Lindl. Extracts. Medicines 2019, 6, 43. https://doi.org/10.3390/medicines6020043

AMA Style

Zhou J-X, Braun MS, Wetterauer P, Wetterauer B, Wink M. Antioxidant, Cytotoxic, and Antimicrobial Activities of Glycyrrhiza glabra L., Paeonia lactiflora Pall., and Eriobotrya japonica (Thunb.) Lindl. Extracts. Medicines. 2019; 6(2):43. https://doi.org/10.3390/medicines6020043

Chicago/Turabian Style

Zhou, Jun-Xian, Markus Santhosh Braun, Pille Wetterauer, Bernhard Wetterauer, and Michael Wink. 2019. "Antioxidant, Cytotoxic, and Antimicrobial Activities of Glycyrrhiza glabra L., Paeonia lactiflora Pall., and Eriobotrya japonica (Thunb.) Lindl. Extracts" Medicines 6, no. 2: 43. https://doi.org/10.3390/medicines6020043

APA Style

Zhou, J. -X., Braun, M. S., Wetterauer, P., Wetterauer, B., & Wink, M. (2019). Antioxidant, Cytotoxic, and Antimicrobial Activities of Glycyrrhiza glabra L., Paeonia lactiflora Pall., and Eriobotrya japonica (Thunb.) Lindl. Extracts. Medicines, 6(2), 43. https://doi.org/10.3390/medicines6020043

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop